Literature DB >> 21876260

Emotional dysfunction in Parkinson's disease.

Lee X Blonder1, John T Slevin.   

Abstract

In addition to motor symptomatology, idiopathic Parkinson's disease is characterized by emotional dysfunction. Depression affects some 30 to 40 percent of Parkinson patients and other psychiatric co-morbidities include anxiety and apathy. Neuropsychological and neuroimaging studies of emotional dysfunction in Parkinson patients suggest abnormalities involving mesolimbic and mesocortical dopaminergic pathways. There is also evidence suggesting that the interaction between serotonin and dopamine systems is important in the understanding and treatment of mood disorders in Parkinson's disease. In this review we discuss the neuropsychiatric abnormalities that accompany Parkinson's disease and describe their neuropsychological, neuropharmacologic, and neuroimaging concomitants.

Entities:  

Mesh:

Year:  2011        PMID: 21876260      PMCID: PMC3177157          DOI: 10.3233/BEN-2011-0329

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  162 in total

1.  Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging.

Authors:  D Berg; T Supprian; E Hofmann; B Zeiler; A Jäger; K W Lange; K Reiners; T Becker; G Becker
Journal:  J Neurol       Date:  1999-12       Impact factor: 4.849

2.  Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies.

Authors:  G Chouinard; B M Saxena; N P Nair; S P Kutcher; D Bakish; J Bradwejn; S H Kennedy; V Sharma; R A Remick; S A Kukha-Mohamad
Journal:  Clin Neuropharmacol       Date:  1992       Impact factor: 1.592

3.  Validity of the 30-item geriatric depression scale in patients with Parkinson's disease.

Authors:  William M McDonald; Paul E Holtzheimer; Michael Haber; Jerrold L Vitek; Kimberly McWhorter; Mahlon Delong
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

Review 4.  Depression associated with Parkinson's disease: clinical features and treatment.

Authors:  Michael S Okun; Ray L Watts
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

Review 5.  Prevalence and treatment of depression in Parkinson's disease.

Authors:  Connie Veazey; Sahinde Ozlem Erden Aki; Karon F Cook; Eugene C Lai; Mark E Kunik
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

6.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

Authors:  Valeria Isella; Paola Melzi; Marco Grimaldi; Simona Iurlaro; Roberto Piolti; Carlo Ferrarese; Lodovico Frattola; Ildebrando Appollonio
Journal:  Mov Disord       Date:  2002-03       Impact factor: 10.338

7.  Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Authors:  Uwe Walter; Jacqueline Hoeppner; Lara Prudente-Morrissey; Sebastian Horowski; Sabine C Herpertz; Reiner Benecke
Journal:  Brain       Date:  2007-02-28       Impact factor: 13.501

8.  Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.

Authors:  Thomas Frodl; Eva M Meisenzahl; Peter Zill; Thomas Baghai; Dan Rujescu; Gerda Leinsinger; Ronald Bottlender; Cornelius Schüle; Peter Zwanzger; Rolf R Engel; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller
Journal:  Arch Gen Psychiatry       Date:  2004-02

9.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

10.  Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.

Authors:  Dennis J Zgaljardic; Joan C Borod; Nancy S Foldi; Mary Rocco; Paul J Mattis; Mark F Gordon; Andrew S Feigin; David Eidelberg
Journal:  Cogn Behav Neurol       Date:  2007-09       Impact factor: 1.600

View more
  32 in total

1.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

2.  Effects of physical activity in Parkinson's disease: A new tool for rehabilitation.

Authors:  Paolo Borrione; Eliana Tranchita; Pierpaolo Sansone; Attilio Parisi
Journal:  World J Methodol       Date:  2014-09-26

3.  Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.

Authors:  Carla Masala; Paolo Solla; A Liscia; G Defazio; L Saba; A Cannas; A Cavazzana; T Hummel; A Haehner
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

Review 4.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

Review 5.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

6.  Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.

Authors:  Hyung-Wook Kim; Won-Seok Choi; Noah Sorscher; Hyung Joon Park; François Tronche; Richard D Palmiter; Zhengui Xia
Journal:  Neurobiol Aging       Date:  2015-05-16       Impact factor: 4.673

Review 7.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

Review 8.  Ghrelin and Neurodegenerative Disorders-a Review.

Authors:  Limin Shi; Xixun Du; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-01-26       Impact factor: 5.590

9.  Affective disorders in Parkinson's disease.

Authors:  Kelly S G Aminian; Antonio P Strafella
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710

Review 10.  The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Authors:  Rebekah G Langston; Iakov N Rudenko; Mark R Cookson
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.